1. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue;Miwa;Eur J Cancer,1998
2. Preferential activation of capecitabine in tumour following oral administration to colorectal cancer patients;Schüller;Cancer Chemother Pharmacol,2000
3. Capecitabine: preclinical pharmacology studies;Ishitsuka;Invest New Drugs,2000
4. Antitumour activity of combination therapy with capecitabine plus vinorelbine, and capecitabine plus gemcitabine in human tumour xenograft models;Sawada;Proc Am Assoc Cancer Res,2002
5. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by Taxol/Taxotere in human cancer xenografts;Sawada;Clin Cancer Res,1998